Comparative study of outcomes between Laparoscopic single anastomosis sleeve ileum bypass (SASI bypass) Versus Laparoscopic Sleeve Gastrectomy for Management of Type II Diabetes and Hypertension in Obese Patients | ||||
| Al-Azhar International Medical Journal | ||||
| Volume 2024, Issue 7, July 2024 | ||||
| DOI: 10.58675/2682-339X.2558 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Magdy Moustafa1; Tarek El Dahshan2; Mohammed Labib1; Ahmed Mohammed1 | ||||
| 1General Surgery, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt | ||||
| 2Clinical Pathology, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt | ||||
| Abstract | ||||
| Background: The global and national epidemic of obesity has emerged. This chronic medical condition goes beyond mere cosmetics; it can result in heart disease, hypertension, diabetes, and other chronic disorders. Aim and objectives: To evaluate the effectiveness of a single perforation sleeve ileal bypass against a sleeve gastroplasty (S.G.) in managing hypertension and diabetes mellitus (D.M.). Patients and methods: This study compared the effects of laparoscopic (SASI) against laparoscopic S.G. on obese individuals with Type 2 diabetes mellitus (T2DM) and hypertension. It was conducted from February 2022 to February 2024 at the General Surgery Department of Al-Azhar University hospitals, involving 30 patients. Results: There was a statistically significant effect of SASI and S.G. on morbidly obese patients with T2DM, improved after a year on body weight and plasma glucose levels, with no statistically significant difference between the two groups for obesity or obesity-related comorbidities (hypertension and hyperlipidemia). Conclusion: When choosing a bariatric operation, the most crucial factors to consider are its safety and effectiveness in helping patients lose weight and reverse the metabolic effects of obesity. | ||||
|
Statistics Article View: 22 |
||||
